https://medicalxpress.com/news/2022-08-immune-cells-genomic-scars-lifetime.html logotype Topics Conditions * Week's top * Latest news * Unread news * Subscribe [ ] Science X Account [ ] [ ] [*] Remember me Sign In Click here to sign in with or Forget Password? Not a member? Sign up Learn more * Addiction * Alzheimer's disease & dementia * Arthritis & Rheumatism * Attention deficit disorders * Autism spectrum disorders * Biomedical technology * Cardiology * Dentistry * Diabetes * Diseases, Conditions, Syndromes * Endocrinology & Metabolism * Gastroenterology * Genetics * Gerontology & Geriatrics * Health * Health informatics * HIV & AIDS * Immunology * Inflammatory disorders * Medical economics * Medical research * Medications * Neuroscience * Obstetrics & gynaecology * Oncology & Cancer * Ophthalmology * Other * Overweight & Obesity * Parkinson's & Movement disorders * Pediatrics * Psychology & Psychiatry * Radiology & Imaging * Sleep apnea * Sports medicine & Kinesiology * Surgery * Vaccination * Asthma * Breast cancer * Cardiovascular disease * Chronic obstructive pulmonary disease * Colon cancer * Coronary artery disease * Dementia * Depression * Heart attack * Heart disease * High blood pressure * Influenza * Kidney disease * Leukemia * Lung cancer * Malaria * Melanoma * Multiple sclerosis * Myocardial infarction * Ovarian cancer * Post traumatic stress disorder * Rheumatoid arthritis * Schizophrenia * Skin cancer * Stroke * Type 2 diabetes * Full List >> * * share this! * 47 * 11 * Share * Email 1. Home 2. Genetics 1. Home 2. Immunology * * * --------------------------------------------------------------------- August 11, 2022 Immune cells acquire genomic scars in a lifetime defending against infection by Wellcome Trust Sanger Institute Immune cells acquire genomic scars in a lifetime defending against infection Comparison of mutational patterns with malignancy. a,b, SNV (a) and structural variation (SV) burden (b) by normal cell type or malignancy. The box shows the interquartile range and the center line shows the median. Whiskers extend to the minimum of either the range or 1.5x the interquartile range. Normal lymphocytes (magenta) exclude pediatric samples. AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; Cut, cutaneous; DLBC, diffuse large B cell. c, The proportion of mutational signatures per genome. For each genome, signatures with a 90% confidence interval lower bound of less than 1% are excluded. Normal lymphocytes (labeled in magenta) are from donor AX001. Treg, T regulatory cells. d,e, SBS9 burden (d) and proportion (e) by cell type or malignancy. The box shows the interquartile range and the center line shows the median. Whiskers extend to the minimum of either the range or 1.5x the interquartile range. f,g, Heat map showing the level of enrichment of SBS9 (f) and SHM (g) signatures near frequently mutated genes for that signature compared with the whole genome. Number of structural variants per group: B cell: 145, T cell: 841, ALL: 523, Burkitt lymphoma: 305, CLL mutated: 252, CLL unmutated: 440, cutaneous T cell lymphoma: 204, DLBC lymphoma: 3,754, follicular lymphoma: 1,095. a,b,d,e, Number of genomes per group: naive B: 68, memory B: 68, naive T: 332, memory T: 87, Burkitt lymphoma: 17, CLL mutated: 38, CLL unmutated: 45, cutaneous T cell lymphoma: 5, DLBC lymphoma: 47, follicular lymphoma: 36, multiple myeloma: 30, myeloid-AML: 10. Credit: Nature (2022). DOI: 10.1038/ s41586-022-05072-7 Immune cells known as lymphocytes have been genetically sequenced in more detail than ever before to investigate how mutations in these cells influence the aging process. Immune cells have been genetically sequenced in higher resolution than ever before, giving insight into how and when they accumulate mutations, such as those linked to the development of certain cancers. In the study, researchers from the Wellcome Sanger Institute, York Biomedical Research Institute at the University of York, and collaborators, created a new protocol that allowed them to grow and sequence colonies of B- and T-cells from a single cell, a technique that could also be used in other areas of research. Published 10 August 2022 in Nature, the research found that the mutations seen in healthy B-cells were largely similar to those seen in cancerous B-cells, suggesting that the development of the cancer arises from the same mutational processes. Understanding more about the factors that cause these mutations to develop into cancer in some cells and not others could help shed light on the origins of this disease. Mutations in these immune cells, known as lymphocytes, may also influence aging and other diseases of the immune system, and finding out more about when and how these occur over a person's lifespan adds to our knowledge about what happens during the aging process. Immune cells known as lymphocytes are a part of the adaptive immune system and includes memory B-cell and memory T-cells, both of which undergo a certain amount of genetic mutation in order to be able to recognize and fight off pathogens. In this new research, the scientists found that while this normal genetic mutation is mostly targeted to the genes for antibodies, a surprising amount of collateral damage occurs elsewhere in the genome. It is this off-target mutation that can lead to lymphocytes becoming cancerous and developing into a type of cancer known as lymphoma. In addition to this, they found that as lymphocytes spread through the body to survey for infections, they are exposed to additional DNA damaging agents, which can further increase the number of mutations. [INS::INS] The team sequenced genomes from over 700 normal immune cells across seven donors, with ages from 0 to 81 years. They found that the number and patterns of mutations in B-cells and T-cells varied extensively from cell to cell. Some of this variation was caused by the accumulation of mutations with age, whereas other variation was caused by off-target damage to the genome from the normal genetic enhancement of antibodies. Plus some variation was caused by DNA damage from sunlight as lymphocytes passed through the skin surveying for infections. The team found that some of the mutations in healthy immune cells were the same as ones already identified in lymphoma, which suggests that lymphomas arise from the same underlying mutational processes as seen in normal immune cells. The considerably greater cell-to-cell variation than person-to-person variation suggests that changes within different areas of the body over a person's lifetime, such as certain infections and inflammation, are more likely to cause mutations linked with cancer and disease than inherited mutations in genes. The research gives more in-depth insight into the mutational landscape of healthy lymphocytes and the processes that cause these mutations, which adds to the current understanding of aging. Further research into how much these mutations and processes vary between tissues is needed to investigate if these offer any avenues for future treatment. "The adaptive immune system changes a lot as we age, but previously it has not been possible to study this in the same level of detail as we have achieved here. Our research is another step towards understanding how mutations in lymphocytes accumulate over time and the impact that these have on the aging process. The protocol we have developed in order to expand cells can also be applied to other areas of research, and we hope that it will be as valuable to other scientists as it is to us," says Dr. Heather Machado, first author from the Wellcome Sanger Institute. "Our research suggests that even though lymphocytes play the same role throughout the body, the mutations that they acquire are linked to their specific tissue environments. These environments could play a larger role in the development of certain lymphomas than inherited mutations. Understanding these processes in greater detail may be able to help shed light on why some of these cells go on to develop into cancer, while others don't," says Dr. David Kent, co-senior author from the York Biomedical Research Institute at the University of York. "Our research begins to fill in the missing gaps in knowledge around how mutations in the adaptive immune system feed into aging. By sequencing around 700 lymphocyte genomes, we have started to build a better picture of the mutational processes that happen over time, and how these relate to the development of lymphoma. While more research is needed, this research gives a strong foundation for further studies into this area," says Dr. Peter Campbell, co-senior author from the Wellcome Sanger Institute. --------------------------------------------------------------------- Explore further Higher rates of mutation alone are not to blame for age-related disease --------------------------------------------------------------------- More information: Heather E. Machado et al, Diverse mutational landscapes in human lymphocytes, Nature (2022). DOI: 10.1038/ s41586-022-05072-7 Journal information: Nature Provided by Wellcome Trust Sanger Institute Citation: Immune cells acquire genomic scars in a lifetime defending against infection (2022, August 11) retrieved 12 August 2022 from https://medicalxpress.com/news/ 2022-08-immune-cells-genomic-scars-lifetime.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. 58 shares * Facebook * Twitter * Email Feedback to editors * Featured * Last Comments * Popular Cortisol concentrations in your hair may reveal how stressed you have been 8 hours ago 0 Study of OTC supplements shows some have very high levels of levodopa, which can lead to paranoia Aug 11, 2022 0 Improving spatial cognition skills also improves verbal reasoning skills, as seen on MRI Aug 11, 2022 0 Monoclonal antibody shown to be effective against malaria for up to six months Aug 04, 2022 1 COVID-19 culture testing suggests some people may remain infectious after five days Aug 04, 2022 0 --------------------------------------------------------------------- [gif] Researchers discover new approach to healing skin infections and wounds 2 hours ago [gif] Rotator cuff regeneration: Potential breakthrough treatment 3 hours ago [gif] When light is the switch: Nanometric photodiodes to study the activity of neurons 5 hours ago [gif] Computational methods can lead to better vaccines faster 5 hours ago [gif] Study reveals neural mechanism of light-promoted early brain development of mammals 6 hours ago [gif] Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions 6 hours ago [gif] A digital tool is helping cancer survivors cope with fear of recurrence 6 hours ago * Related Stories [gif] Higher rates of mutation alone are not to blame for age-related disease Oct 01, 2021 [gif] Cellular secrets of ageing unlocked by researchers Jun 01, 2022 [gif] Mutations across animal kingdom shed new light on aging Apr 13, 2022 [gif] Gene expression profile allows identification of anti-tumor immune cells for personalized immunotherapy Feb 04, 2022 [gif] Researchers find number of mutations in human B lymphocytes increases with age Apr 18, 2019 [gif] Uncovering the pathway to colon cancer Oct 23, 2019 * Recommended for you [gif] The aging heart accumulates mutations--while losing the ability to repair them 6 hours ago [gif] 'Abnormal' protein could be common link between all forms of motor neuron disease 8 hours ago [gif] Protection against COVID-19: Experience is not always an advantage for the immune response 8 hours ago [gif] Powerful new antibody neutralizes all known SARS-CoV-2 variants Aug 11, 2022 [gif] Study uncovers what happens inside artery plaque to trigger strokes Aug 11, 2022 [gif] Not all in the genes: Are we inheriting more than we think? Aug 11, 2022 Load comments (0) Let us know if there is a problem with our content Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines). Please select the most appropriate category to facilitate processing of your request [-- please select one -- ] [ ] [ ] [ ] [ ] [ ] Your message to the editors [ ] Your email (only if you want to be contacted back) [ ] Send Feedback Thank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages. E-mail the story Immune cells acquire genomic scars in a lifetime defending against infection Your friend's email [ ] Your email [ ] [ ] I would like to subscribe to Science X Newsletter. Learn more Your name [ ] Note Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form. [ ] [ ] [ ] [ ] [ ] [ ] [ ] Your message [ ] Send Newsletter sign up Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties. [ ] Subscribe More information Privacy policy Phys.org Phys.org Daily science news on research developments and the latest scientific innovations Tech Xplore Tech Xplore The latest engineering, electronics and technology advances ScienceX Science X The most comprehensive sci-tech news coverage on the web Newsletters [ ] Subscribe Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox Follow us * * * * * Top * Home * Search * Mobile version * Help * FAQ * About * Contact * Science X Account * Sponsored Account * Newsletter * Archive * Android app * iOS app * RSS feeds * Push notification (c) Medical Xpress 2011 - 2022 powered by Science X Network Privacy policy Terms of use Medical Disclaimer Your Privacy This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use. I'm OK with that Cookie options E-mail newsletter [ ] Subscribe Follow us * * * * It appears that you are currently using Ad Blocking software. What are the consequences? x Quantcast